MOSCOW, Apr 6 (PRIME) -- Russian biopharmaceutical company Generium has registered an express test for the COVID-19 in the country’s Federal Service for Supervision of Healthcare, the Industry and Trade Ministry said in a statement on Monday.
“This is the first national express test that detects the coronavirus within 40 minutes, including preparation of test samples, with the correctness rate of 94% using standard equipment,” the statement read.
End %%md/jst%%
|
|
